- Home
- GFF vs PTGX Comparison
GFF vs PTGX Comparison
Compare GFF & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFF
- PTGX
- Stock Information
- Founded
- GFF 1959
- PTGX 2006
- Country
- GFF United States
- PTGX United States
- Employees
- GFF N/A
- PTGX N/A
- Industry
- GFF Building Products
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- GFF Industrials
- PTGX Health Care
- Exchange
- GFF Nasdaq
- PTGX Nasdaq
- Market Cap
- GFF 3.3B
- PTGX 2.9B
- IPO Year
- GFF N/A
- PTGX 2016
- Fundamental
- Price
- GFF $68.61
- PTGX $53.34
- Analyst Decision
- GFF Strong Buy
- PTGX Strong Buy
- Analyst Count
- GFF 4
- PTGX 9
- Target Price
- GFF $99.00
- PTGX $67.11
- AVG Volume (30 Days)
- GFF 291.7K
- PTGX 898.5K
- Earning Date
- GFF 08-06-2025
- PTGX 08-05-2025
- Dividend Yield
- GFF 1.05%
- PTGX N/A
- EPS Growth
- GFF 30.60
- PTGX N/A
- EPS
- GFF 4.82
- PTGX 0.86
- Revenue
- GFF $2,551,604,000.00
- PTGX $207,801,000.00
- Revenue This Year
- GFF N/A
- PTGX N/A
- Revenue Next Year
- GFF $3.02
- PTGX $47.15
- P/E Ratio
- GFF $14.17
- PTGX $62.27
- Revenue Growth
- GFF N/A
- PTGX N/A
- 52 Week Low
- GFF $55.01
- PTGX $30.67
- 52 Week High
- GFF $86.73
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- GFF 47.34
- PTGX 58.33
- Support Level
- GFF $67.13
- PTGX $54.48
- Resistance Level
- GFF $72.65
- PTGX $57.18
- Average True Range (ATR)
- GFF 1.45
- PTGX 2.04
- MACD
- GFF -0.20
- PTGX -0.09
- Stochastic Oscillator
- GFF 32.89
- PTGX 57.13
About GFF Griffon Corporation
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.